Man Group plc

Position in BEAM — Beam Therapeutics Inc.

CIK 1637460 LONDON, X0

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,455,422

-$1,072,994 QoQ

Shares Held

129,820

-44.0% QoQ

Ownership

0.126%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#62

of 274 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,094,353,895 across 113 Biotechnology names. BEAM ranks #38 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	436,956	$272,459,544
2	INCY	Incyte Corp	952,941	$108,025,391
3	ONC	BeOne Medicines Ltd.	307,463	$87,617,731
4	VRTX	Vertex Pharmaceuticals Inc / Ma	139,233	$69,161,207
5	APGE	Apogee Therapeutics, Inc.	397,000	$52,693,809
6	ALNY	Alnylam Pharmaceuticals, Inc.	170,907	$51,448,133
7	JAZZ	Jazz Pharmaceuticals plc	152,877	$36,838,770
8	RVMD	Revolution Medicines, Inc.	173,439	$32,481,655

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,455,422	129,820	-44.0%	Shares	Defined	2026-08-14
2026-03-31	$5,528,416	231,994	+223.5%	Shares	Defined	2026-05-15
2025-09-30	$1,740,644	71,720	+8.8%	Shares	Defined	2025-11-14
2023-09-30	$315,463	13,117	+31.6%	Principal	Defined	2023-11-14
2023-06-30	$2,105,591	65,944	+463.7%	Shares	Defined	2023-08-14
2023-03-31	$305,097	9,964	-89.3%	Principal	Defined	2023-05-15
2022-06-30	$3,611,991	93,309	—	Principal	Defined	2022-08-15
2022-03-31	$670,295	11,698	+70.6%	Shares	Defined	2022-05-16
2021-03-31	$548,913	6,858	+153.5%	Shares	Defined	2021-05-17
2020-12-31	$220,835	2,705	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.